Insider Transactions in Q4 2025 at Dia Medica Therapeutics Inc. (DMAC)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
73,099
+0.82%
|
$584,792
$8.57 P/Share
|
|
Nov 24
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,253
+0.46%
|
$281,771
$7.89 P/Share
|
|
Nov 21
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
208,872
+2.34%
|
$1,462,104
$7.41 P/Share
|
|
Nov 21
2025
|
James T. Parsons |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+12.02%
|
$24,000
$2.2 P/Share
|
|
Nov 20
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
128,426
+1.49%
|
$898,982
$7.41 P/Share
|
|
Nov 19
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
240,352
+2.79%
|
$1,682,464
$7.21 P/Share
|
|
Nov 18
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
182,882
+2.2%
|
$1,097,292
$6.75 P/Share
|
|
Nov 17
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
187,393
+2.3%
|
$1,124,358
$6.52 P/Share
|